Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study. - Siebenhaar F; Broesby-Olsen S; Castells M; George TI; Livideanu CB; Álvarez-Twose I; Panse J; Barete S; Reiter A; Dybedal I; Akin C; Van Daele P; et al. (Journal of the American Academy of Dermatology, 2026)